News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Roche (JOBS) Seen Upping $42 Billion Genentech, Inc. (JOBS) Bid After Rebuff
February 24, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ZURICH, Feb 24 (Reuters) - Roche will likely have to up its bid for the 44 percent of Genentech it does not own, analysts said on Tuesday, after the U.S. biotech group urged shareholders to reject the offer.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
Genentech, Inc.
Roche
MORE ON THIS TOPIC
Funding
Degron adds $40M to series A, supporting immunology plans for molecular glue platform
May 14, 2026
·
2 min read
·
Tristan Manalac
Job Trends
Hiring outlook: job opportunities on
BioSpace
rise YOY, but layoffs affect thousands
May 14, 2026
·
3 min read
·
Angela Gabriel
Manufacturing
Bora inks $122.5M takeover of MacroGenics facility to further US expansion
May 13, 2026
·
2 min read
·
Nick Paul Taylor
Earnings
Goodbye Galapagos: chameleon company exits the island, rebrands as Lakefront
May 13, 2026
·
2 min read
·
Heather McKenzie